NEPHROGENEX, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementNephroGenex, Inc. • August 7th, 2015 • Pharmaceutical preparations • New York
Company FiledAugust 7th, 2015 Industry JurisdictionNephroGenex, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows: